MedTrace Logo

The Safety and Efficacy of Radiofrequency Ablation After Left Atrial Appendage Occlusion.

NCT06984731 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 210

Last updated 2025-05-22

No results posted yet for this study

Summary

Objective: To evaluate the safety and efficacy of transcatheter atrial fibrillation ablation 1 month after WATCHMAN FLX left atrial appendage closure in patients with nonvalvular atrial fibrillation.

Conditions

Interventions

PROCEDURE

left atrial appendage closure

Patients with atrial fibrillation underwent transcatheter radiofrequency cardiac ablation 1 month after left atrial appendage closure with WATCHMAN FLX

PROCEDURE

radiofrequency ablation

Patients with atrial fibrillation underwent transcatheter radiofrequency cardiac ablation 1 month after left atrial appendage closure with WATCHMAN FLX

Sponsors & Collaborators

  • Affiliated Hospital of Nantong University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-21
Primary Completion
2027-06-01
Completion
2028-06-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06984731 on ClinicalTrials.gov